Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
$7.95 -0.13 (-1.61%)
As of 03:59 PM Eastern

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Key Stats

Today's Range
$7.95
$8.12
50-Day Range
$6.24
$8.12
52-Week Range
$4.79
$8.58
Volume
1.27 million shs
Average Volume
752,776 shs
Market Capitalization
$31.24 billion
P/E Ratio
N/A
Dividend Yield
0.25%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

BAYRY Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at $4.88 on January 1st, 2025. Since then, BAYRY stock has increased by 62.9% and is now trading at $7.95.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) announced its quarterly earnings results on Tuesday, May, 13th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.02. The business had revenue of $15.27 billion for the quarter, compared to the consensus estimate of $13.39 billion. Bayer Aktiengesellschaft had a positive trailing twelve-month return on equity of 13.94% and a negative net margin of 7.26%.

The following companies are subsidiaries of Bayer Aktiengesellschaft: Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and more.

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 5/12 Dividend
4/29/2025
Record date for 5/12 Dividend
4/30/2025
Dividend Payable
5/12/2025
Last Earnings
5/13/2025
Today
7/18/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Large Cap Pharma
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
CIK
1144145
Employees
92,815
Year Founded
1863

Profitability

EPS (Trailing Twelve Months)
($0.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
6.15
P/E Growth
N/A
Net Income
-$2.76 billion
Net Margins
-7.26%
Pretax Margin
-6.83%
Return on Equity
13.94%
Return on Assets
4.09%

Debt

Debt-to-Equity Ratio
1.07
Current Ratio
1.25
Quick Ratio
0.79

Sales & Book Value

Annual Sales
$50.44 billion
Price / Sales
0.63
Cash Flow
$3.78 per share
Price / Cash Flow
2.13
Book Value
$8.82 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
3,929,700,000
Free Float
N/A
Market Cap
$31.63 billion
Optionable
Not Optionable
Beta
0.86

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:BAYRY) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners